Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Sep 6;293(6547):577–580. doi: 10.1136/bmj.293.6547.577

Modern management of non-Hodgkin's lymphoma.

G M Mead, J M Whitehouse
PMCID: PMC1341374  PMID: 3092931

Full text

PDF
577

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Katib A., Koziner B., Kurland E., Little C., Labriola D., Thaler H., Straus D., Lee B., Clarkson B. Treatment of diffuse poorly differentiated lymphocytic lymphoma. An analysis of prognostic variables. Cancer. 1984 Jun 1;53(11):2404–2412. doi: 10.1002/1097-0142(19840601)53:11<2404::aid-cncr2820531107>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  2. Armitage J. O., Fyfe M. A., Lewis J. Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen. J Clin Oncol. 1984 Aug;2(8):898–902. doi: 10.1200/JCO.1984.2.8.898. [DOI] [PubMed] [Google Scholar]
  3. Blair T. J., Evans R. G., Buskirk S. J., Banks P. M., Earle J. D. Radiotherapeutic management of primary thyroid lymphoma. Int J Radiat Oncol Biol Phys. 1985 Feb;11(2):365–370. doi: 10.1016/0360-3016(85)90159-2. [DOI] [PubMed] [Google Scholar]
  4. Cohen L. F., Balow J. E., Magrath I. T., Poplack D. G., Ziegler J. L. Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med. 1980 Apr;68(4):486–491. doi: 10.1016/0002-9343(80)90286-7. [DOI] [PubMed] [Google Scholar]
  5. Gatter K. C., Alcock C., Heryet A., Mason D. Y. Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet. 1985 Jun 8;1(8441):1302–1305. doi: 10.1016/s0140-6736(85)92794-1. [DOI] [PubMed] [Google Scholar]
  6. Goffinet D. R., Warnke R., Dunnick N. R., Castellino R., Glatstein E., Nelsen T. S., Dorfman R. F., Rosenberg S. A., Kaplan H. S. Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. Cancer Treat Rep. 1977 Sep;61(6):981–992. [PubMed] [Google Scholar]
  7. Greer J. P., York J. C., Cousar J. B., Mitchell R. T., Flexner J. M., Collins R. D., Stein R. S. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. J Clin Oncol. 1984 Jul;2(7):788–798. doi: 10.1200/JCO.1984.2.7.788. [DOI] [PubMed] [Google Scholar]
  8. Hamblin T. J., Abdul-Ahad A. K., Gordon J., Stevenson F. K., Stevenson G. T. Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces. Br J Cancer. 1980 Oct;42(4):495–502. doi: 10.1038/bjc.1980.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hoppe R. T., Kushlan P., Kaplan H. S., Rosenberg S. A., Brown B. W. The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation. Blood. 1981 Sep;58(3):592–598. [PubMed] [Google Scholar]
  10. Horning S. J., Doggett R. S., Warnke R. A., Dorfman R. F., Cox R. S., Levy R. Clinical relevance of immunologic phenotype in diffuse large cell lymphoma. Blood. 1984 May;63(5):1209–1215. [PubMed] [Google Scholar]
  11. Horning S. J., Rosenberg S. A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med. 1984 Dec 6;311(23):1471–1475. doi: 10.1056/NEJM198412063112303. [DOI] [PubMed] [Google Scholar]
  12. Isaacson P. G., O'Connor N. T., Spencer J., Bevan D. H., Connolly C. E., Kirkham N., Pollock D. J., Wainscoat J. S., Stein H., Mason D. Y. Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet. 1985 Sep 28;2(8457):688–691. doi: 10.1016/s0140-6736(85)92930-7. [DOI] [PubMed] [Google Scholar]
  13. Isaacson P., Wright D. H. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer. 1984 Jun 1;53(11):2515–2524. doi: 10.1002/1097-0142(19840601)53:11<2515::aid-cncr2820531125>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  14. Isaacson P., Wright D. H. Intestinal lymphoma associated with malabsorption. Lancet. 1978 Jan 14;1(8055):67–70. doi: 10.1016/s0140-6736(78)90004-1. [DOI] [PubMed] [Google Scholar]
  15. Kim H., Hendrickson R., Dorfman R. F. Composite lymphoma. Cancer. 1977 Sep;40(3):959–976. doi: 10.1002/1097-0142(197709)40:3<959::aid-cncr2820400302>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  16. Klimo P., Connors J. M. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med. 1985 May;102(5):596–602. doi: 10.7326/0003-4819-102-5-596. [DOI] [PubMed] [Google Scholar]
  17. Longo D. L., Young R. C., Hubbard S. M., Wesley M., Fisher R. I., Jaffe E., Berard C., DeVita V. T., Jr Prolonged initial remission in patients with nodular mixed lymphoma. Ann Intern Med. 1984 May;100(5):651–656. doi: 10.7326/0003-4819-100-5-651. [DOI] [PubMed] [Google Scholar]
  18. Magrath I. T., Janus C., Edwards B. K., Spiegel R., Jaffe E. S., Berard C. W., Miliauskas J., Morris K., Barnwell R. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood. 1984 May;63(5):1102–1111. [PubMed] [Google Scholar]
  19. Mead G. M., Kushlan P., O'Neil M., Burke J. S., Rosenberg S. A. Clinical aspects of non-Hodgkin's lymphomas presenting with discordant histologic subtypes. Cancer. 1983 Oct 15;52(8):1496–1501. doi: 10.1002/1097-0142(19831015)52:8<1496::aid-cncr2820520827>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  20. Mead G. M., Macbeth F. R., Ryall R. D., Williams C. J., Whitehouse J. M. A report on a prospective trial of no initial therapy in patients with initial therapy in patients with asymptomatic favourable prognosis non-Hodgkin's lymphoma. Hematol Oncol. 1984 Apr-Jun;2(2):179–188. doi: 10.1002/hon.2900020207. [DOI] [PubMed] [Google Scholar]
  21. Mead G. M., Macbeth F. R., Williams C. J., Ryall R. D., Wright D. H., Whitehouse J. M. Poor prognosis non-Hodgkin's lymphoma in the elderly: clinical presentation and management. Q J Med. 1984 Summer;53(211):381–390. [PubMed] [Google Scholar]
  22. Mead G. M., Mackintosh F. R., Burke J. S., Rosenberg S. A. Late relapse from complete remission in nodular and diffuse histiocytic lymphoma. Cancer. 1983 Oct 15;52(8):1356–1359. doi: 10.1002/1097-0142(19831015)52:8<1356::aid-cncr2820520803>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  23. Meeker T. C., Lowder J., Maloney D. G., Miller R. A., Thielemans K., Warnke R., Levy R. A clinical trial of anti-idiotype therapy for B cell malignancy. Blood. 1985 Jun;65(6):1349–1363. [PubMed] [Google Scholar]
  24. Meeker T., Lowder J., Cleary M. L., Stewart S., Warnke R., Sklar J., Levy R. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N Engl J Med. 1985 Jun 27;312(26):1658–1665. doi: 10.1056/NEJM198506273122602. [DOI] [PubMed] [Google Scholar]
  25. Miller T. P., Jones S. E. Initial chemotherapy for clinically localized lymphomas of unfavorable histology. Blood. 1983 Aug;62(2):413–418. [PubMed] [Google Scholar]
  26. Monfardini S., Banfi A., Bonadonna G., Rilke F., Milani F., Valagussa P., Lattuada A. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 1980 Feb;6(2):125–134. doi: 10.1016/0360-3016(80)90027-9. [DOI] [PubMed] [Google Scholar]
  27. Moore I., Wright D. H. Primary gastric lymphoma--a tumour of mucosa-associated lymphoid tissue. A histological and immunohistochemical study of 36 cases. Histopathology. 1984 Nov;8(6):1025–1039. doi: 10.1111/j.1365-2559.1984.tb02418.x. [DOI] [PubMed] [Google Scholar]
  28. Nadler L. M., Takvorian T., Botnick L., Bast R. C., Finberg R., Hellman S., Canellos G. P., Schlossman S. F. Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet. 1984 Aug 25;2(8400):427–431. doi: 10.1016/s0140-6736(84)92907-6. [DOI] [PubMed] [Google Scholar]
  29. Paryani S. B., Hoppe R. T., Cox R. S., Colby T. V., Rosenberg S. A., Kaplan H. S. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II. Cancer. 1983 Dec 15;52(12):2300–2307. doi: 10.1002/1097-0142(19831215)52:12<2300::aid-cncr2820521224>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  30. Rudders R. A., Ross M. E., DeLellis R. A. Primary extranodal lymphoma: response to treatment and factors influencing prognosis. Cancer. 1978 Aug;42(2):406–416. doi: 10.1002/1097-0142(197808)42:2<406::aid-cncr2820420205>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  31. Slater D. E., Mertelsmann R., Koziner B., Higgins C., McKenzie S., Schauer P., Gee T., Straus D., Kempin S., Arlin Z. Lymphoblastic lymphoma in adults. J Clin Oncol. 1986 Jan;4(1):57–67. doi: 10.1200/JCO.1986.4.1.57. [DOI] [PubMed] [Google Scholar]
  32. Smith B. R., Weinberg D. S., Robert N. J., Towle M., Luther E., Pinkus G. S., Ault K. A. Circulating monoclonal B lymphocytes in non-Hodgkin's lymphoma. N Engl J Med. 1984 Dec 6;311(23):1476–1481. doi: 10.1056/NEJM198412063112304. [DOI] [PubMed] [Google Scholar]
  33. Tseng A., Jr, Coleman C. N., Cox R. S., Colby T. V., Turner R. R., Horning S. J., Rosenberg S. A. The treatment of malignant histiocytosis. Blood. 1984 Jul;64(1):48–53. [PubMed] [Google Scholar]
  34. Vokes E. E., Ultmann J. E., Golomb H. M., Gaynor E. R., Ferguson D. J., Griem M. L., Oleske D. Long-term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol. 1985 Oct;3(10):1309–1317. doi: 10.1200/JCO.1985.3.10.1309. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES